Literature DB >> 11949824

Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation.

Jean-Jacques Dubost1, Christine Rolhion, Andrei Tchirkov, Suzanne Bertrand, Jacques Chassagne, Annie Dosgilbert, Pierre Verrelle.   

Abstract

We investigated the production of interleukin 6 (IL-6) by a radioresistant human glioblastoma cell line G5 after single radiation events of 3, 6 and 9 Gy. The total cell number and IL-6 concentration in culture supernatant were assessed 24-96 h after irradiation. The radiation impeded or stopped G5 cell growth in a dose-dependent manner, but unexpectedly did not affect the IL-6 concentration in cell culture media that increased in the same range as in non-irradiated cultures. Furthermore, using flow cytometry, we found that the IL-6 positive cells expansion was unaffected by radiation. These findings suggested that this small (about 1%) fraction of G5 cells, constitutively producing IL-6, is highly radioresistant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949824     DOI: 10.1023/a:1014467804488

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Induction of chromosomal aberrations and growth-transformation of lymphoblastoid cell lines by inhibition of reactive oxygen species-induced apoptosis with interleukin-6.

Authors:  H Miwa; H Kanno; S Munakata; Y Akano; M Taniwaki; K Aozasa
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

2.  Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

Authors:  D Puthier; S Derenne; S Barillé; P Moreau; J L Harousseau; R Bataille; M Amiot
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

3.  Interleukin-6 overexpression as a marker of malignancy in human gliomas.

Authors:  C Rolhion; F Penault-Llorca; J L Kémény; J J Lemaire; C Jullien; C Labit-Bouvier; F Finat-Duclos; P Verrelle
Journal:  J Neurosurg       Date:  2001-01       Impact factor: 5.115

4.  Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG.

Authors:  S Goswami; A Gupta; S K Sharma
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

Review 5.  Control of programmed cell death in normal and leukemic cells: new implications for therapy.

Authors:  L Sachs; J Lotem
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

6.  Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.

Authors:  C Huettner; W Paulus; W Roggendorf
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

7.  Immune infiltrates and cytokines in gliomas.

Authors:  B Giometto; F Bozza; F Faresin; L Alessio; S Mingrino; B Tavolato
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

Authors:  Y Mizutani; B Bonavida; Y Koishihara; K Akamatsu; Y Ohsugi; O Yoshida
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

9.  Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.

Authors:  C Lu; C Sheehan; J W Rak; C A Chambers; N Hozumi; R S Kerbel
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

10.  Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor.

Authors:  R Neta; R Perlstein; S N Vogel; G D Ledney; J Abrams
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  10 in total

1.  Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.

Authors:  Johannes E A Wolff; Sabine Wagner; Christiane Reinert; Astrid Gnekow; R-D Kortmann; Joachim Kühl; Stefaan W Van Gool
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

2.  P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.

Authors:  Marjorie A Curet; Jyoti J Watters
Journal:  J Neurooncol       Date:  2017-11-30       Impact factor: 4.130

Review 3.  Cytokine networks in glioma.

Authors:  Kenichiro Iwami; Atsushi Natsume; Toshihiko Wakabayashi
Journal:  Neurosurg Rev       Date:  2011-06-09       Impact factor: 3.042

4.  Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro.

Authors:  Bo Qiu; Dongyong Zhang; Yong Wang; Shaowu Ou; Jun Wang; Jun Tao; Yunjie Wang
Journal:  Clin Exp Metastasis       Date:  2013-07-06       Impact factor: 5.150

5.  Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.

Authors:  Jonathan B Lamano; Jason Balquidera Lamano; Yuping D Li; Joseph D DiDomenico; Winward Choy; Dorina Veliceasa; Daniel E Oyon; Shayan Fakurnejad; Leonel Ampie; Kartik Kesavabhotla; Rajwant Kaur; Gurvinder Kaur; Dauren Biyashev; Dusten J Unruh; Craig M Horbinski; C David James; Andrew T Parsa; Orin Bloch
Journal:  Clin Cancer Res       Date:  2019-03-01       Impact factor: 12.531

6.  Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors.

Authors:  Vassilis Samaras; Christina Piperi; Penelope Korkolopoulou; Athanasios Zisakis; Georgia Levidou; Marios S Themistocleous; Efstathios I Boviatsis; Damianos E Sakas; Robert W Lea; Anastasios Kalofoutis; Efstratios Patsouris
Journal:  Mol Cell Biochem       Date:  2007-06-06       Impact factor: 3.396

7.  IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.

Authors:  Yuichiro Matsuoka; Hideki Nakayama; Ryoji Yoshida; Akiyuki Hirosue; Masashi Nagata; Takuya Tanaka; Kenta Kawahara; Junki Sakata; Hidetaka Arita; Hikaru Nakashima; Satoru Shinriki; Daiki Fukuma; Hidenao Ogi; Akimitsu Hiraki; Masanori Shinohara; Ryo Toya; Ryuji Murakami
Journal:  Br J Cancer       Date:  2016-10-13       Impact factor: 7.640

8.  Acquisition of radioresistance by IL-6 treatment is caused by suppression of oxidative stress derived from mitochondria after γ-irradiation.

Authors:  Yuki Tamari; Genro Kashino; Hiromu Mori
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

9.  Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.

Authors:  Pedram Tabatabaei; Eward Visse; Per Bergström; Thomas Brännström; Peter Siesjö; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2016-09-23       Impact factor: 4.130

Review 10.  The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy.

Authors:  Erica C F Yeo; Michael P Brown; Tessa Gargett; Lisa M Ebert
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.